The effects of immunizing cattle against either of two peptides from the amino terminal peptide (\ g=a\ N) of the \g=a\43-subunit of bovine inhibin on ovulation rate, gonadotrophin concentration and fertility were investigated. Two peptide sequences from the \g=a\N-subunit of bovine inhibin (PIN, and P2N, bI\g=a\-(153-167)) were synthesized and conjugated to human serum albumin (HSA). Hereford-cross heifers (n = 5 per group) were given an initial injection of 3 mg of one of the peptide conjugates, followed by three booster injections (1.5 mg) at intervals of 11 weeks. Control heifers (n = 5) were injected with HSA only. Blood samples were taken once a week to measure antibody titre and every hour at about the time of the first oestrus and during the mid-luteal phase after the second booster injection, to measure FSH and LH concentrations. Ovulation rate was measured by ultrasonography. Gonadotrophin concentrations were analysed for four periods relative to the peak (time = 0 h) of the preovulatory LH surge as follows: pre-surge: -16 to -5 h; surge: -4 to 4 h; post-surge: 5 to 16 h and a period of 12 h during the mid-luteal (days 10-12) phase. Antibodies that bound to the individual peptides were generated and the ovulation rate increased (P < 0.05) in immunized heifers. Control heifers had one ovulation at all ovulatory cycles monitored. In group PIN, one heifer had two ovulations at each of the six cycles monitored, while another heifer had two ovulations at one cycle. Three heifers in group P2N had more than one ovulation; one heifer had a superovulation response on seven occasions and another heifer on three occasions while the third heifer had two ovulations at one cycle. The superovulation responses ranged from three to eight ovulations. There was no evidence of a significant correlation between peptide antibody titre, ovulation rate and FSH at any of the periods studied. After mating following the third booster injection, nine of the ten immunized and all five control heifers calved. One heifer from group PIN and two heifers from group P2N gave birth to twin calves. These data show that in cattle immunization against the aN-subunit of bovine inhibin significantly disrupts the mechanism(s) controlling ovulation rate but does not impair fertility. O'Shea et al, 1994) . In contrast, immunization against the terminal amino subunit ( ) of pro-a-bovine inhibin blocked ovulation in sheep (Findlay et al, 1989a, b) . Although this indicates a possible intra-ovarian role for the ctN-subunit of inhibin in sheep, there are no similar published data for cattle.
Introduction
Immunoneutralization of inhibin by active immunization using partly purified inhibin, recombinant -inhibin or synthetic peptides derived from the inhibin a-subunit has resulted in an increased ovulation rate in sheep and cattle (see Forage et al, combined with the ac peptide and ß-subunit, gives rise to the 5 7 kDa form of inhibin; and finally a pro-ac peptide (for reviews see Vale et al, 1991; Baird and Smith, 1993) . None of the a-subunits has inhibin-like (FSH suppressing) activity (Sugino et al, 1989; Vale et al, 1991; Baird and Smith, 1993) .
However, Schneyer et al. (1991) reported that the prepro-protein modulated FSH-receptor binding; while Findlay et al. (1989a, b) found that immunization against the aN-subunit blocked ovulation in sheep. Active immunization against inhibin, using synthetic peptides derived from the carboxy region of the a-subunit (ac), resulted in significant increases in ovulation rate in sheep (Wrathall et al, 1990; O'Shea et al, 1994) and cattle (Glencross et al, 1992 (Glencross et al, , 1994 Morris et al, 1993; Scanion et al, 1993) . This paper describes the effect of active immunization of cattle against two synthetic peptide sequences from the bovine inhibin aN-subunit on peptide antibody titre, ovulation rate, FSH and LH concentrations and fertility.
Materials and Methods

Sequence identification
The amino acid sequence of the bovine inhibin aNsubunit (Forage et al, 1986 ) was analysed by hydrophilicity and secondary structure methods (Morris et al, 1993) to predict likely antigenic sites. Two peptide sequences from the aN-subunit: PIN, Gly21Cys22: YGRRGSEPEDQDVSQGC; P2N, Cys168: YTRAKPPSGGERARRSC were identified as potential epitopes and were synthesized by solid phase methods as described by Morris et al (1993) . The natural sequences were modified during synthesis by the addition of either tyrosyl or cystenyl residues, linked through a glycine spacer where appropriate, to facilitate iodination and conjugation, respectively.
Peptide conjugation
Each peptide was conjugated to human serum albumin (HSA) and conalbumin (Sigma, Poole, Dorset) using the heterobifunctional reagent --maleimido-butyryloxysuccinimide (GMBS; Calbiochem, Lucerne) as described by Morris et al (1993) . The conjugation rate was determined by amino acid analysis of the conjugate following hydrolysis according to the method of Briand et al (1985) . For each complex, approxi¬ mately 10-20 moles of peptide were bound per mole of carrier. Peptide conjugates were stored as lyophilized powders at -25°C until required for immunization.
Immunization
Fifteen nulliparous Hereford-cross heifers, approximately 18 months old and of body mass 360 ± 8 kg (mean ± sem) were randomly allocated, in equal numbers (n = 5), to two treatment and one control group. Inhibin rxN peptide-HSA conjugates (3 mg) were dissolved in 2 ml saline (0.85%, w/v, NaCl), emulsified in an equal quantity of Freund's complete adjuvant (Difco, Detroit, MI) and injected into four sites in the brisket region. Three booster injections (1.5 mg of conjugate) were similarly prepared, emulsified in non-ulcerative Freund's adjuvant (NUFA; Guildhea Antisera, Guildford, Surrey) and administered at intervals of 11 weeks. The control group was immunized with HSA carrier only. Blood samples were taken immediately before (pre-immune) and at regular intervals after immunization (immune) by jugular venepuncture. The blood samples were collected into 10 ml tubes without additive (Vacutainer; Beckton Dickinson, Crowley) and allowed to clot for 1 h at 37°C. After centrifugation at 1000 # for 30 min, the serum was removed and stored at -25°C until antibody titres were measured.
Antibody titres
Antibody titres to the peptides used for immunization were determined using an ELISA as described by Morris et al (1993) .
Briefly, microtitre plate wells were coated with 100 µ of peptide (2 µ 1~: ) as a peptide-conalbumin conjugate and incubated with fourfold dilutions of serum, beginning at a dilution of 1:100. the binding of antibody from immunized heifers was determined by incubation with horseradish peroxidase-labelled rabbit anti-bovine immunoglobulin (Dakopatts, Glostrup) followed by 0-phenylene-diamine/H2O2 visualization. Titre was expressed as the reciprocal dilution of serum required to give an absorbance of 0.5 at 492 nm under the assay conditions used.
Oestrous and ovarian responses
Five days after each booster injection, the oestrous cycles of heifers were synchronized with a short-term (9 day) progestagen (Sreenan and Mulvehill, 1975) . Twenty four hours before pessary removal each heifer received a luteolytic dose (15 mg) of prostaglandin (Prosolvin: Intervet, Cambridge) i.m. At the time of progestagen removal, heifers were tail-painted to aid detection of oestrus and were observed four times a day for standing oestrus. After the second booster injection, and 24 h after progestagen pessary removal, blood samples were taken at intervals of 1 h for up to 92 h from four heifers in each group, via an indwelling jugular vein catheter, to determine systemic concentrations of FSH and LH. Standing oestrus was not recorded during this period for four of the five heifers in each group as heifers were tied in stanchions. Samples were also taken at hourly intervals for 12 h during the following mid-luteal phase of the cycle. Blood samples were taken into defined as the concentration of standard (USDA-BLH-I-2; D. J.
Bolt, USDA, Beltsville, MD) statistically distinguishable from zero concentration, was 0.25 ng ml~. The inter-and intraassay coefficients of variation for a pool of plasma having a mean LH concentration of 1.43 ng ml-x were 14.7% and 8.1%, respectively. The detection limit of the FSH assay was 3.4 ng standard ml "1 (USDA-BFSH-B-1; D. J. Bolt). The inter-and intra-assay coefficients of variation for a pool of plasma having a mean FSH concentration of 14.1 ng ml-1 were 12.1% and 8.0%, respectively.
Conception and calving rate
Heifers were mated at the synchronized oestrus and at the first repeat oestrus after the third booster injection. The number of fetuses present 45 days after mating was counted by ultrasonography and at parturition the number of calves born was recorded.
Statistical analyses
The data were analysed using anova procedures (Harvey, 1987) to fit a model that allowed for the fact that repeated measures were made on the same heifer, and included the effect of immunization treatment, heifers within treatment, booster number, number of cycles and the interaction of treatment with booster number. The main effect of treatment was tested using the heifer within treatment mean square as the error term. The treatment by booster number interaction was analysed in more detail, by comparing booster number within treatment, and treatment within booster number using the Student-Newman-Keul's test. Ovarian measurements taken during the fourth oestrous cycle were made on only a small number of heifers; therefore, these observations were assigned to cycle number three for anova. Ovulation rate data were included in the analysis only for those heifers ovulating. Gonadotrophin con¬ centrations, in blood samples taken at intervals of 1 h during four periods relative to the peak of the preovulatory LH surge (hour 0), were also analysed by anova for repeated measures:
pre-surge ( -16 to -5 h), during the surge ( -4 to 4 h), after the surge (5 to 16 h) and a period of 12 h during the mid-luteal (days 10-12) phase. During the preovulatory surge, the statis¬ tical model used tested the effect of treatment only. Data from one heifer in group PIN (No. 5) and in the control group (No. 12) did not show a preovulatory LH or FSH surge during the sampling period and were excluded from the statistical analysis. Data from all heifers are included, however, in the mid-luteal phase analysis. The immune and ovulatory responses to the peptide immunization were examined in relation to peripheral concentrations of FSH. Before analysis, peptide titres were log transformed to approximate normal variâtes. Correlations, calculated on a pooled within-treatment basis, between ovu¬ lation rate and FSH concentration during period 1 and between peptide titre and FSH were examined by regression analysis.
Correlations between ovulation rate in the first oestrous cycle following a booster injection and peptide titre 14 days after a booster injection (2-3 days before oestrus) were examined by regression analysis. The peptide antibody titre is presented Values are means followed by 95% confidence limits of the mean of three booster injections with numbers of observations in parentheses followed by the range.
aMeans with different superscripts are significantly different (P < 0.05}.
after back-transformation. A value of < 0.05 was considered significant.
Results
Immune response
Antibodies were generated against each of the peptides, and titres reached a maximum between 7 and 21 days after a booster injection (Fig. 1 ). The highest peptide titres recorded for individual animals within groups PIN and P2N were 124 450 and 418 847, respectively. Peptide titres measured in the HSA-immunized control heifers and in pre-immune sera were all less than 100. There was a significant effect of treatment (P<0.05) on the immune response, measured 14 days after a booster injection, and peptide P2N gave a higher antibody titre than did PlN (Table 1 ). However, there was no effect of booster number on antibody titre.
Oestrous and ovarian response
The proportion of heifers showing oestrus was not affected by immunization. Standing oestrus was observed for 23 of 32 Peptide immunization increased the ovulation rate overall (P < 0.05), and there was no difference between the treatment groups ( Table 2 ). Number of cycles following a booster did not affect the ovulation rate. However, there was a significant treatment by booster number interaction (P < 0.01) on ovu¬ lation rate (Table 3 ). In the control group, the ovulation rate was 1.0 at each ovulatory cycle throughout the immunization period. Two of five and three of five heifers and 7 of 36 (19%) and 11 of 37 (30%) ovulatory cycles observed following immunization against PlN and P2N, respectively, had more than one ovulation. A total of 18 multiple ovulatory cycles were recorded, nine (50%) of which were twin-ovulatory. Of these nine twin-ovulatory cycles, seven were recorded in group PlN with six of these attributed to one heifer. In contrast, there was a superovulation response in group P2N. The ovulation rate in nine of the multiple ovulatory cycles ranged from three to eight ovulations, with seven (78%) of these attributed to one heifer. There was no correlation between peptide titre measured around the first oestrous cycle after each of the three booster injections and the subsequent ovulation rate during the cycle. Conception and calving rates Nine of the ten peptide-immunized heifers and four of the five control heifers conceived to first service, as determined by ultrasonography at day 45 (Table 6 ). The remaining two heifers conceived to the second service. Of the four heifers with multiple pregnancies at day 45, two had twin fetuses and produced twin calves at term, while the third had three fetuses and produced twin calves at term. The remaining heifer had seven ovulations and had four fetuses at day 45, all of which were subsequently lost. All six of the single-ovulating peptideimmunized heifers and all of the single-ovulating control heifers pregnant at day 45 subsequently calved.
Discussion
Immunization against either of two synthetic peptides derived from the aM-subunit of bovine inhibin increased the ovulation rate but did not affect either overt oestrous behaviour or duration of the oestrous cycle. Although the number of animals involved in this study was small, there was no apparent adverse effect on fertility following immunization. To our knowledge this is the first report of the effect of immunizing cattle using aN-inhibin peptides as immunogens. Immunization against peptide P2N generated a higher peptide antibody titre; however, there was no effect of booster number on the immune response. The apparently higher titre in the P2N group after the first booster injection is due to a superimposition of the response to booster 1 on the response to the primary injection.
The response to PlN was similar, but was smaller. The higher overall titre recorded for the P2N group may be related to differences in the coating densities of the capture peptide conjugates or due to conformational changes of the peptides in the solid phase ELISA (Van Regenmortel, 1988) . True differ¬ ences in the immune response to the different peptides may have been revealed by measuring the ability of the different antibodies to bind to the full length a43-subunit (aN + ac) or to biologically active 58 kDa inhibin, but these were not readily available. However, the immune response to each of three different peptides from the ac-subunit of bovine inhibin was similar whether measured by a solid phase ELISA or a liquid phase radioimmunoassay (Morris et al, 1993) .
Ovulation rate was increased in both of the peptideimmunized groups. Although the maximum response in group PIN was two ovulations, a superovulation response was recorded in the P2N group with responses of up to seven and eight ovulations. Some heifers had an increased ovulation rate on up to seven occasions and this response continued up to the fourth oestrous cycle after a booster injection. There was a significant treatment by booster number interaction, on the ovulation response. This was due to an increase in ovulation rate in three of the group P2N heifers after the third booster, compared with only one heifer in group PlN and also to an increase in the ovulation rate of these three heifers after booster number 3 when compared with boosters 1 and 2. In contrast to the results presented here, Findlay et al (1989a, b) and Russell et al (1994a) reported that immunization of sheep against the full recombinant aN-subunit of bovine inhibin results in an increase in the number of corpora lutea-like structures and in a suppression of ovulation, owing to failure in oocyte release. Russell et al (1994b) indicated that the ovu¬ lation failure was probably due to a reduction in the activity of metalloproteinase-2 and other enzymes involved in the re¬ modelling of the follicle wall to facilitate oocyte release and corpus luteum formation. In the study reported here, the number of corpora lutea present on the ovaries was determined by ultrasonography and used as an index of the ovulation rate. However, it is unlikely that ovulation was impaired in peptideimmunized heifers, since after mating following booster 3, all multiple ovulating heifers had at least two fetuses at 45 days after mating, while all single ovulating heifers became pregnant.
The mechanism(s) controlling ovulation rate was clearly more disrupted after immunization with P2N than with either immunization with PlN or peptides derived from the inhibin ac-subunit as previously described by Morris et al (1993) , despite being similarly conjugated to HSA. It is not clear how this increase in ovulation rate was effected. Immunization did not affect LH concentrations at any of the periods measured. The mean FSH concentration tended to be higher in group P2N during period 1 after booster 2 compared with PIN or controls, and although this was not statistically significant may, nevertheless, have affected the ovulation rate. FSH concen¬ trations of the two peptide-immunized groups were sig¬ nificantly different at the mid-luteal phase but were not significantly different from controls. However, in previous studies, in which heifers were immunized with inhibin peptides derived from the ac-subunit, a positive association was found between inhibin binding and ovulation rate (Morris et al, 1993) and between inhibin binding and FSH (Morris et al, 1995) , but not between FSH and ovulation rate (Morris el al, 1995) . The relatively controlled increase in ovulation rate in the report of Morris et al (1993) occurred mainly in the first cycle after a booster and decreased in subsequent cycles as physiological compensation occurred and free antibody titres decreased. In contrast, in the study reported here, a superovulation response was recorded in some immunized heifers, and this response extended up to the fourth oestrous cycle after a booster.
Glencross et al (1994) indicated that immunization of heifers against a peptide from the inhibin ac-subunit led to a sustained increase in plasma FSH concentration and that this increase was associated with an increase in ovulation rate. However, these authors found no association between FSH and ovulation rate.
Although this data and that of others (Glencross et al, 1992; Morris et al, 1995) suggest a role for inhibin in the control of ovulation rate by modulating peripheral FSH concentration, it does not exclude possible paracrine or autocrine effects of inhibin or inhibin-related peptides at the ovary in the control of ovulation (Schneyer el al, 1991; Baird and Smith 1993) . However, FSH concentrations were measured only after the second booster in the study reported here, and if the increase in ovulation rate was due solely to an increase in FSH concen¬ trations, it is unlikely that the ovulation rate in subsequent cycles would be affected in the way that they are. There was no evidence of a significant correlation between peptide antibody titre, FSH and ovulation rate. The highest FSH concentration during period 1 (32.1 ng ml-1) was recorded for heifer 7 in group P2N, with three ovulations. However, in the same group, for heifer 8, with four ovulations, the mean FSH concentration was 15.1 ng ml" during the same period, similar to that for the control heifers. The principal effect of inhibin immunoneutralization on ovulation may be at the ovary, and increased peripheral FSH concentrations have a facilitative role. Schneyer et al (1991) identified a probable competitor for FSH receptors in follicular fluid as the 57 kDa a-inhibin precursor protein. This finding may indicate that in the present study immunization against inhibin neutralized some autocrine or paracrine effect of inhibin, attributable to the rxN-subunit, the free a-subunit or precursor protein, distinct from the systemic effect of inhibin on pituitary FSH secretion.
Immunization against the aN-peptides did not affect concep¬ tion rate. Findlay el al (1989a, b) reported that immunization of sheep against a recombinant bovine rxN-peptide impaired fertility in sheep by blocking ovulation, despite an increase in the number of apparent corpora lutea per ewe. Russell el al.
(1994a) have since confirmed these findings and reported an increase in FSH concentrations of immunized ewes with a significant negative association between immunoreactive inhibin concentrations and binding during the follicular phase. Russell et al (1994b) also reported that immunization against the aN-subunit reduces preovulatory matrix metalloproteinase 2 activity in follicular fluid, suggesting an intraovarian role for aN in the process of ovulation and formation of corpora lutea in sheep.
In summary, immunization against peptides derived from the aN-subunit of bovine inhibin elicited an immune response and increased ovulation rate in cattle and, in contrast to results in sheep, had no detrimental effect on fertility.
